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BSTRACT
 
Background
 
Osteoporosis is a common disorder
with a strong genetic component. One way in which
the genetic component could be expressed is through
polymorphism of 
 
COLIA1
 
, the gene for collagen type
I
 
a
 
1, a bone-matrix protein.
 
Methods
 
We determined the 
 
COLIA1
 
 genotypes
 
SS, Ss,
 
 and 
 
ss
 
 in a population-based sample of 1778
postmenopausal women using a polymerase-chain-
reaction–based assay. We then related the geno-
types to bone mineral density and the occurrence of
osteoporotic fractures in these women.
 
Results
 
As compared with the 1194 women with
the 
 
SS
 
 genotype, the 526 women with the 
 
Ss
 
 geno-
type had 2 percent lower bone mineral density at
the femoral neck (P
 

 
0.003) and the lumbar spine
(P
 

 
0.02); the 58 women with the 
 
ss
 
 genotype had
reductions of 4 percent at the femoral neck (P
 

 
0.05)
and 6 percent at the lumbar spine (P
 

 
0.005). These
differences increased with age (P
 

 
0.01 for modifica-
tion by age of the effect of 
 
COLIA1
 
 on femoral-neck
bone density, and P
 

 
0.004 for modification of the ef-
fect on lumbar-spine bone density). Women with the
 
Ss
 
 and 
 
ss
 
 genotypes were overrepresented among
the 111 women who had incident nonvertebral frac-
tures (relative risk per copy of the 
 
s
 
 allele, 1.5; 95 per-
cent confidence interval, 1.1 to 2.1).
 
Conclusions
 
The 
 
COLIA1
 
 polymorphism is associ-
ated with reduced bone density and predisposes
women to osteoporotic fractures. (N Engl J Med
1998;338:1016-21.)
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STEOPOROSIS is a common disorder
characterized by reduced bone mineral
density, deterioration of the microarchi-
tecture of bone tissue, and increased risk
of fracture.
 
1
 
 Evidence from twin and family studies
suggests that genetic factors have a major role in
the pathogenesis of osteoporosis,
 
2-6
 
 and segregation
analysis has shown that bone mineral density is un-
der polygenic control.
 
7
 
 Pedigree studies of mono-
genetic disorders have been conducted to identify
genes that could subsequently be analyzed for their
contribution to the pathogenesis of osteoporosis on
a population-wide basis. For example, loss-of-func-
tion mutations in the gene for the vitamin D receptor
are responsible for the bone disease that characterizes
1
 
a
 
,25-dihydroxyvitamin D–resistant rickets.
 
8,9
 
 Some,
O
 
but not all, subsequent population-based and twin
studies found that polymorphisms of the vitamin D
receptor were associated with differences in bone
density.
 
10,11
 
 A man with a loss-of-function mutation
of the estrogen-receptor gene had osteoporosis,
 
12
 
but intronic polymorphisms of this gene have not
been consistently associated with differences in bone
density in population-based studies of women.
 
13,14
 
Similarly, girls with loss-of-function mutations in
the aromatase P450 gene, who cannot synthesize
estrogen, have osteoporosis,
 
15
 
 but no population-
based studies of this gene have been published. In
more recent pedigree studies, a locus for “high peak
bone density” and the locus for the osteoporosis–
pseudoglioma syndrome, a recessive disorder charac-
terized by juvenile-onset blindness and osteoporosis,
were mapped to the same region on chromosome
11,
 
16,17
 
 suggesting the presence of a gene with effects
on bone density. Polymorphisms of other candidate
genes, such as the genes for interleukin-6 and trans-
forming growth factor 
 
b
 
, have also been associated
with differences in bone density in some popula-
tions.
 
18,19
 
The genes encoding collagen types I
 
a
 
1 and I
 
a
 
2
(
 
COLIA1
 
 and 
 
COLIA2,
 
 respectively) are also im-
portant candidates for the genetic regulation of
bone density, because mutations that affect the cod-
ing regions of these genes cause osteogenesis im-
perfecta.
 
20
 
 Although the coding regions of collagen
genes are normal in the vast majority of patients with
osteoporosis,
 
21
 
 we described a novel guanine-to-thy-
midine polymorphism at the first base of a binding
site for the transcription factor Sp1 in the first intron
of the 
 
COLIA1
 
 gene that was associated with low
bone density and increased occurrence of osteo-
porotic vertebral fracture in 299 British women.
 
22
 
To determine whether this polymorphism predicts
bone density and the risk of osteoporotic fracture in
other populations, we studied the relation of the
 
COLIA1
 
 polymorphism to bone density and os-
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teoporotic fracture in 1778 postmenopausal women
in the Netherlands.
 
23
 
METHODS
 
Study Subjects
 
The Rotterdam Study is a population-based cohort study of
7983 subjects who are at least 55 years old and who live in the
Ommoord district of Rotterdam, the Netherlands. The study was
designed to document the occurrence of disease in the elderly in
relation to several potential determinants.
 
23
 
 A total of 10,275 per-
sons, of whom 9161 (89 percent) were living independently, were
invited to participate in the study in 1991. Among the subjects
living independently, the overall response rate was 77 percent for
the home interview and 71 percent for the examination in a re-
search center, where anthropometric characteristics and bone
mineral density were measured and blood samples were taken.
The Rotterdam Study was approved by the medical ethics com-
mittee of the Erasmus University Medical School, and written in-
formed consent was obtained from each subject.
The association between the 
 
COLIA1
 
 genotype and osteo-
porosis was analyzed in a subgroup of women participating in the
study. Base-line measurements of bone mineral density were avail-
able for 5931 subjects who were living independently. Of these,
1453 were excluded because they were more than 80 years of age,
used a walking aid, had diabetes mellitus, or were taking diuretics,
estrogen, thyroid hormone, or cytostatic drugs. From the 4478
remaining subjects, we studied a random sample of 2000 women
who were 55 to 80 years old. Bone-density data or DNA samples
were not available for 222 women, resulting in a final study group
of 1778 women.
 
Measurements
 
Height and weight were measured at the initial examination,
with the subject in a standing position without shoes. Bone min-
eral density (in grams per square centimeter) was determined by
dual-energy x-ray absorptiometry (DPX-L densitometer, Lunar,
Madison, Wis.) at the femoral neck and lumbar spine (vertebrae
L2, L3, and L4), as described elsewhere.
 
24
 
 Dietary intake of cal-
cium (in milligrams per day) during the preceding year was as-
sessed by a food-frequency questionnaire and adjusted for energy
intake. Age at menopause and current use of cigarettes and alco-
hol were assessed by questionnaire. For 1423 women (80 per-
cent), lateral radiographs of the spine from the fourth thoracic to
the fifth lumbar vertebra were obtained at base line and examined
for the presence of prevalent vertebral fractures by morphometric
analysis, as previously described.
 
25
 
 Incident nonvertebral fractures,
including hip, wrist, and other fractures, were recorded, con-
firmed, and classified by a physician over a mean follow-up period
of 3.8 years.
 
Determination of 
 
COLIA1
 
 Genotypes
 
Genomic DNA was extracted from samples of peripheral
venous blood according to standard procedures, and the intronic
polymorphism of the 
 
COLIA1
 
 gene was detected by the polymer-
ase chain reaction (PCR) with a mismatched primer that intro-
duces a diallelic restriction site, as previously described.
 
22
 
 The test
discriminates two alleles, 
 
S
 
 and 
 
s,
 
 which correspond to the pres-
ence of guanine and thymidine, respectively, as the first bases in
the Sp1-binding site in the first intron of the gene for 
 
COLIA1.
 
The reaction mixture of 25 
 
m
 
l contained 100 ng of genomic
DNA, 50 mM potassium chloride, 10 mM TRIS–hydrochloric
acid (pH 8.3), 1.5 mM magnesium chloride, 0.2 mM dideoxynu-
cleotide triphosphates, 150 ng of each primer, and 0.2 unit of Su-
per 
 
Taq
 
 polymerase (HT Biotechnology, Cambridge, United
Kingdom). The reactions were performed in a DNA thermocycler
(mode 480, Perkin–Elmer, Foster City, Calif.) with a cycling pro-
tocol of 94°C, 60°C, and 72°C for one minute each, for 35 cy-
cles. Ten microliters of PCR product was digested with 2 units of
 
Msc
 
I restriction enzyme and 1.2 
 
m
 
l of a buffer, containing 150
mM TRIS–hydrochloric acid (pH 7.5), 250 mM sodium chlo-
ride, and 35 mM magnesium chloride, by incubation for 30 min-
utes at 37°C. The digestion products underwent electrophoresis
on a 3 percent NuSieve agarose gel (FMC BioProducts, Rock-
land, Me.) in 44.5 mM TRIS, 44.5 mM boric acid, and 1 mM
disodium EDTA for 300 volt-hours. The separation patterns were
documented by Polaroid photography under ultraviolet illumina-
tion (302 nm). To confirm the accuracy of the genotyping, re-
peated analysis was performed on 400 randomly selected samples,
including those from all 
 
ss
 
 homozygotes. No discrepancies were
found.
 
Statistical Analysis
 
Bone mineral density and other relevant clinical variables of the
three genotype groups were compared by analysis of covariance.
Multiple linear regression was used to adjust bone-density values
for confounding factors such as age, anthropometric variables,
calcium intake, smoking, and alcohol use. A multivariate linear re-
gression model was designed to test for the changing effects of
 
COLIA1
 
 genotype on bone density with age. For this analysis,
the subjects were classified into five-year age groups (55 to 59, 60
to 64, 65 to 69, 70 to 74, and 75 to 80 years), and the 
 
COLIA1
 
genotypes were assigned values of 0, 1, or 2, according to the
number of 
 
s
 
 alleles present. The analysis included an interaction
term defined as age group multiplied by gene dose (the number
of 
 
s
 
 alleles). The variance of bone density that could be explained
by the 
 
COLIA1
 
 genotype was calculated by linear regression anal-
ysis adjusted for weight and age. The chi-square test was used to
test for Hardy–Weinberg equilibrium, the distribution of alleles
in women of different age groups, and the distribution of alleles
in women with and without fractures. Odds ratios (with 95 per-
cent confidence intervals) were calculated by multivariate logistic-
regression analysis to estimate the relative risk of osteoporotic
fracture. All statistical tests were two-sided.
 
RESULTS
 
Characteristics of the Study Subjects
 
Table 1 shows anthropometric, dietary, and bone-
density measurements according to 
 
COLIA1
 
 gen-
otype. The allelic frequencies (82 percent for the
 
S
 
 allele and 18 percent for the 
 
s
 
 allele) and the dis-
tribution of genotypes were similar to those report-
ed in a previous study
 
22
 
 and were as predicted by the
Hardy–Weinberg equation, confirming that no gen-
otype was being selectively sampled (P
 

 
1.00). The
three genotype groups did not differ significantly in
age, age at menopause, dietary calcium intake, smok-
ing habits, alcohol intake, or height. There was a sig-
nificant gene-dose effect on body weight (
 

 
0.97 kg
per copy of the 
 
s
 
 allele, P
 

 
0.03): body weight was
lower in the 
 
Ss
 
 group than in the 
 
SS 
 
group, and low-
est in the 
 
ss 
 
group.
Association between Genotype and Bone Mineral Density
The three genotype groups differed significantly
in bone mineral density at the femoral neck and the
lumbar spine. At both sites, bone mineral density
was highest in the SS group and lowest in the ss
group (Table 1). Bone mineral density in the Ss
group was 2 percent less than that in the SS group
at both sites (P0.003 for femoral neck and
P0.02 for lumbar spine). In the ss group, bone
mineral density in the femoral neck was 4 percent
Copyright © 1998 Massachusetts Medical Society. All rights reserved. 
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less than that in the SS group (P0.05), and in the
lumbar spine it was 6 percent less than that in the SS
group (P0.005). Table 2 shows that these differ-
ences corresponded to significant gene-dose effects
at the femoral neck and lumbar spine (P0.001 for
both sites). The effects of COLIA1 genotype on
bone density of the Ward’s triangle and trochanter
sites at the hip were similar (data not shown). The
percentage of the variance in bone density explained
by the COLIA1 genotype was 0.3 percent at the
femoral neck and 0.4 percent at the lumbar spine.
When the bone-density values were adjusted for
confounding variables resulting from the association
between genotype and body weight, the differences
between genotype groups were smaller, but they
were still statistically significant.
Age-Related Changes in the Association between 
Genotype and Bone Mineral Density
Bone density declines with age, and genetic ef-
fects on bone density could theoretically be mediat-
ed by differences in the age-related rate of bone
loss,26 as well as by differences in peak bone density.
We therefore assessed the effect of age on the rela-
tion between COLIA1 genotype and bone density.
When the study subjects were divided into five-year
age categories, the differences in bone density be-
tween the genotype groups were small among the
younger women (55 to 65 years old) but became
larger with increasing age (Fig. 1). Among women
75 to 80 years of age, bone mineral density in the Ss
group was 5 percent lower at the femoral neck
(P0.03) and 3 percent lower at the lumbar spine
(P0.26) than that in the SS group. In the ss group,
bone mineral density was 12 percent lower at the
femoral neck (P0.04) and 20 percent lower at the
lumbar spine (P0.004) than that in the SS group.
These numbers indicate an increased gene-dose ef-
fect with increasing age at both the femoral neck
and the lumbar spine (Table 2).
When age, genotype, and bone density were con-
sidered together in a multivariate regression model,
we found that age significantly modified the effect
of the COLIA1 genotype on bone density, at both
the femoral neck (P0.01 for the interaction term)
and the lumbar spine (P0.004 for the interaction
term). The percentage of the variance in bone den-
sity accounted for by the COLIA1 genotype became
larger with age, reaching 2 percent for women 75 to
80 years of age. These differences were not explained
by differences in the distribution of genotypes, be-
cause the allelic frequencies did not change with in-
*Plus–minus values are means SD. ANOVA denotes analysis of variance.
†Values are adjusted for age and weight.
TABLE 1. CHARACTERISTICS OF 1778 POSTMENOPAUSAL WOMEN 
ACCORDING TO THEIR COLIA1 GENOTYPE.*
CHARACTERISTIC COLIA1 GENOTYPE P VALUE
SS (N1194) SS (N526) SS (N58) ANOVA SS VS. SS SS VS. SS
Age (yr) 667 667 667 0.72 0.57 0.90
Height (cm) 1626 1626 1626 0.96 0.80 0.86
Weight (kg) 69.310.6 68.510.1 66.88.6 0.08 0.11 0.07
Age at menopause (yr) 495 495 495 0.82 0.83 0.70
Dietary calcium intake (mg/day) 1103324 1111344 1064268 0.61 0.67 0.38
Current smoker (%) 21 20 16 0.52 0.82 0.20
Bone mineral density (g/cm2)
Femoral neck
Unadjusted
Adjusted†
Lumbar spine
Unadjusted
Adjusted†
0.820.13
0.820.13
1.030.17
1.030.17
0.800.12
0.810.12
1.010.17
1.010.17
0.790.13
0.800.13
0.970.19
0.980.19
0.003
0.03
0.003
0.02
0.003
0.01
0.02
0.07
0.05
0.17
0.005
0.02
*Plus–minus values are means SE.
TABLE 2. COLIA1 GENE-DOSE EFFECT ON BONE DENSITY 
OF POSTMENOPAUSAL WOMEN ACCORDING TO AGE.*
AGE (YR)
NO. OF
WOMEN
CHANGE AT
FEMORAL NECK 
PER S ALLELE* P VALUE
CHANGE AT 
LUMBAR SPINE 
PER S ALLELE* P VALUE
g/cm2 g/cm2
55–59
60–64
65–69
70–74
75–80
422
463
376
307
210
0.0050.012
0.0090.010
0.0170.012
0.0310.012
0.0430.016
0.67
0.38
0.18
0.01
0.01
0.0010.015
0.0130.014
0.0200.017
0.0520.017
0.0580.023
0.93
0.36
0.24
0.002
0.01
Total 1778 0.0180.006 0.001 0.0250.008 0.001
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creasing age and the distribution of genotypes in
each age group was similar to that in the study
group as a whole.
Association between Genotype and Fractures
Table 3 shows the distribution of incident nonver-
tebral fractures and prevalent vertebral compression
fractures according to COLIA1 genotype. Significant-
ly more women with the Ss genotype had incident
nonvertebral fractures or prevalent vertebral fractures
than women with the SS genotype. Among women
with the ss genotype, this difference increased for in-
cident nonvertebral fractures (P0.02) but not for
prevalent vertebral fractures (P0.33).
Logistic-regression analysis showed that for inci-
dent nonvertebral fractures, the women in the Ss
group had 1.4 times the risk of the women in the SS
group, and the women in the ss group had 2.8 times
the risk of the women in the SS group. The overall
gene-dose effect was an odds ratio of 1.5 per copy
of the s allele: 3.1 for the hip (95 percent confidence
interval, 1.2 to 7.6; 10 cases), 1.4 for the wrist (95
percent confidence interval, 0.8 to 2.5; 36 cases),
and 1.4 for other fractures (95 percent confidence
interval, 0.9 to 2.1; 65 cases). The risk of vertebral
fracture was slightly increased in women in the Ss
group but not in those in the ss group. The relative
risk of fracture did not change after adjustment for
potential confounding factors such as age, weight,
and bone density in the regression analysis (Table 3).
DISCUSSION
Genetic factors have an important role in deter-
mining bone density,2-6,27 and bone density is an im-
portant determinant of the risk of osteoporotic frac-
ture.28,29 The genes for collagen types Ia1 and Ia2
(COLIA1 and COLIA2) are important candidates for
regulators of bone density and risk of fracture, be-
cause point mutations that affect their coding re-
gions result in osteogenesis imperfecta.20 Although
similar mutations in the coding regions of the col-
lagen genes have not been found in patients with os-
teoporosis,21 the polymorphism that we described,
which affects a binding site for the transcription fac-
tor Sp1 in a regulatory region of the COLIA1 gene,
was associated with differences in bone density and
risk of fracture in 299 British women.22 The data
presented here confirm and extend these findings to
a population-based cohort of 1778 postmenopausal
women from the Netherlands. We found a consis-
tent association between this COLIA1 polymor-
phism and differences in bone density at the spine
and hip, with evidence of gene-dose effects at both
sites: bone-density values were highest in women
with the SS genotype, intermediate in those with the
Ss genotype, and lowest in those with the rare ss gen-
otype.
These differences in bone density were accompa-
nied by differences in body weight, and the differ-
ence between genotypes in bone density was re-
duced in magnitude after correction for weight. This
is not unexpected in view of the close association
between weight and bone density30,31 and suggests
that the association between COLIA1 genotype and
bone density may be mediated in part by a genetic
effect of COLIA1 on body weight.
The genotype-specific differences in bone density
Figure 1. Mean (SE) Age-Related Differences in Bone Miner-
al Density of the Femoral Neck (Panel A) and Lumbar Spine
(Panel B) in Postmenopausal Women According to COLIA1
Genotype.
The numbers of women with each genotype in each age group
are shown below the figure. The asterisks denote P0.05, and
the dagger P0.01 for the comparison with the SS genotype.
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were small in the study group as a whole but in-
creased with age. The allelic frequencies did not
change with age, an observation that argues against
selection bias due to mortality-related effects of the
polymorphism as an explanation for this effect. This
raises the possibility that the COLIA1 polymor-
phism may be a marker for accelerated bone loss in
older women, rather than a marker for lower peak
bone density.
The overrepresentation of the Ss and ss genotypes
among women with osteoporotic fractures was not
unexpected, in view of the well-established relation
between bone density and risk of fracture,28,29 which
was also found in this study. The relative risk of frac-
ture, however, was about two to three times as great
as that predicted by the differences between geno-
types in bone density, and it remained significant af-
ter adjustment for weight and bone density. This
raises the possibility that the COLIA1 polymorphism
may act as a marker for differences in bone quality,
such as bone structure or matrix composition, as well
as bone quantity. The number of fractures was small,
however.
The mechanisms by which the different COLIA1
alleles affect bone density and fracture risk are not
known. Oligonucleotides corresponding to the s al-
lele bind the Sp1 protein with greater affinity than
those corresponding to the S allele,32 and subjects
who are heterozygous for the polymorphism have
three times as many transcripts derived from the s al-
lele as from the S allele (unpublished data). This
raises the possibility that carriage of the s allele may
be associated with a disturbance in the relative abun-
dance of COLIA1 and COLIA2 messenger RNAs, as
occurs in osteogenesis imperfecta.33
Studies of the genetic basis of osteoporosis are im-
portant to identify genes that act as regulators of
bone density, bone quality, and the risk of fracture.
Genetic markers for osteoporosis could be useful
clinically for identifying subjects at risk of osteo-
porosis and for targeting preventive treatment. The
association we describe between COLIA1 genotype
and osteoporotic fracture in postmenopausal wom-
en, coupled with the divergence of bone-density val-
ues with increasing age between different genotype
groups, raises the possibility that genotyping at the
polymorphic COLIA1 Sp1 site may provide infor-
mation on susceptibility to osteoporotic fracture that
could complement information gained from bone-
density measurements alone.
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